Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**8-Bromoadenosine-5'-Diphosphate** is a synthetic, brominated analog of adenosine diphosphate (ADP), belonging to the class of purine ribonucleoside diphosphates. It is primarily used as a biochemical tool in research settings, particularly for receptor mapping studies and as a starting structure for synthesizing other modified ADP derivatives. The introduction of a bromine atom at the eighth position on the adenine ring alters its syn/anti ratio and can affect its interaction with nucleotide-binding proteins or enzymes. There are no known clinical indications or therapeutic uses; it is not approved for medical use and remains an experimental compound[2][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 8-bromoadenosine-5'-diphosphate.